Results 191 to 200 of about 168,140 (338)
ABSTRACT Background and Objectives Pelvic exenteration is a curative option for select patients with locally invasive or recurrent colorectal cancer. Achieving clear margins (R0 resection) is critical for optimal oncological outcomes and quality of life.
Ernest Cheng+7 more
wiley +1 more source
Case Series: Natural History and Treatment of Thoracic Aortic Sarcoma
ABSTRACT Aortic sarcoma is a rare and aggressive malignancy with a poor prognosis despite surgical resection and vascular reconstruction. We present a case series of patients with thoracic aortic sarcoma, highlighting three distinct clinical scenarios: primary resection, resection following prior thoracic aortic endograft, and nonoperative management ...
Calvin L. Chao+2 more
wiley +1 more source
Brazilian Society of Surgical Oncology: Guidelines for the Lymphadenectomy in Colorectal Cancer
ABSTRACT The BSSO developed the present guidelines to provide recommendations based on current scientific evidence that is focused on the main topics related to the daily surgical practice of lymphadenectomy in colorectal cancer. Between October 2024 and February 2025, nine experts met to develop the guidelines for the lymphadenectomy in colorectal ...
Jorge Mali+8 more
wiley +1 more source
A pathological study of tumour regression in oesophageal adenocarcinoma treated with preoperative chemoradiotherapy [PDF]
B Dunne+4 more
openalex +1 more source
ABSTRACT Aim To compare oncological outcomes of short‐course radiation therapy (SCRT) versus long‐course chemoradiation (LCRT) in patients with low rectal cancer, particularly in a high‐volume center with expertise in extended total mesorectal excision (TME).
Tejas Vispute+8 more
wiley +1 more source
A Resected Case of Pancoast Tumor with Concurrent Induction Chemoradiotherapy.
宏 沖津+5 more
openalex +2 more sources
ABSTRACT Lugol chromoendoscopy is widely used for screening esophageal squamous cell neoplasms (ESCNs) and evaluating dissection margins during endoscopic submucosal dissection (ESD). However, morphological variations may arise following treatment for synchronous cancers.
Wen‐Hung Hsu+8 more
wiley +1 more source